Cargando…

Serum Levels of Surfactant Proteins in Patients with Combined Pulmonary Fibrosis and Emphysema (CPFE)

INTRODUCTION: Emphysema and idiopathic pulmonary fibrosis (IPF) present either per se or coexist in combined pulmonary fibrosis and emphysema (CPFE). Serum surfactant proteins (SPs) A, B, C and D levels may reflect lung damage. We evaluated serum SP levels in healthy controls, emphysema, IPF, and CP...

Descripción completa

Detalles Bibliográficos
Autores principales:	Papaioannou, Andriana I., Kostikas, Konstantinos, Manali, Effrosyni D., Papadaki, Georgia, Roussou, Aneza, Spathis, Aris, Mazioti, Argyro, Tomos, Ioannis, Papanikolaou, Ilias, Loukides, Stelios, Chainis, Kyriakos, Karakitsos, Petros, Griese, Matthias, Papiris, Spyros
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4919090/ https://www.ncbi.nlm.nih.gov/pubmed/27337142 http://dx.doi.org/10.1371/journal.pone.0157789

Ejemplares similares

Pulmonary hemorrhage in patients receiving anti-platelets- a case series and a suggested therapeutic algorithm
por: Tomos, Ioannis, et al.
Publicado: (2022)

Survival in Idiopathic pulmonary fibrosis acute exacerbations: the non-steroid approach
por: Papiris, Spyros A, et al.
Publicado: (2015)

Revisiting IL-13 blockade: can we reach the wonderland the inhaled way?
por: Papaioannou, Andriana I., et al.
Publicado: (2018)

Sputum interleukin (IL)-13 as a biomarker for the evaluation of asthma control
por: Tsilogianni, Zoi, et al.
Publicado: (2015)

Combined Pulmonary Fibrosis and Emphysema (CPFE) Clinical Features and Management
por: Hage, René, et al.
Publicado: (2021)

Massive hemoptysis in a patient with pulmonary embolism, a real therapeutic conundrum
por: Herodotou, Yiolanda, et al.
Publicado: (2017)

Exhaled breath condensate pH as a biomarker of COPD severity in ex-smokers
por: Papaioannou, Andriana I, et al.
Publicado: (2011)

The Impact of Lung Cancer in Patients with Combined Pulmonary Fibrosis and Emphysema (CPFE)
por: Feng, Xiaoyi, et al.
Publicado: (2023)

Lung transplantation outcome in adult surfactant-related interstitial lung disease: first evidence to move on
por: Manali, Effrosyni D., et al.
Publicado: (2023)

Sestrin 2 levels are associated with emphysematous phenotype of COPD
por: Angelakis, Leonidas, et al.
Publicado: (2022)

Eosinopenia as a Prognostic Biomarker for Noninvasive Ventilation Use in COPD Exacerbations
por: Bartziokas, Konstantinos, et al.
Publicado: (2023)

The Value of CT for Disease Detection and Prognosis Determination in Combined Pulmonary Fibrosis and Emphysema (CPFE)
por: Choi, Seung Hee, et al.
Publicado: (2014)

IgG4-related disease presenting with combined pulmonary fibrosis and emphysema (CPFE)
por: Kono, Masato, et al.
Publicado: (2018)

Primary care and COVID-19: cutting the Gordian knot – the Greek experience and algorithm
por: Tomos, Ioannis, et al.
Publicado: (2020)

Long-term personal air pollution exposure and risk for acute exacerbation of idiopathic pulmonary fibrosis
por: Tomos, Ioannis, et al.
Publicado: (2021)

Identification of asthma phenotypes using blood cell count
por: Papaioannou, Andriana I, et al.
Publicado: (2022)

Control of asthma in real life: still a valuable goal?
por: Papaioannou, Andriana I., et al.
Publicado: (2015)

Differential Genomic Profile in TERT, DSP, and FAM13A Between COPD Patients With Emphysema, IPF, and CPFE Syndrome
por: Guzmán-Vargas, Javier, et al.
Publicado: (2021)

The Gly82Ser mutation in AGER contributes to pathogenesis of pulmonary fibrosis in combined pulmonary fibrosis and emphysema (CPFE) in Japanese patients
por: Kinjo, Takumi, et al.
Publicado: (2020)

Reduced immunogenicity of the mRNA vaccine BNT162b2 in patients with idiopathic pulmonary fibrosis
por: Karampitsakos, Theodoros, et al.
Publicado: (2022)

Bi-allelic missense ABCA3 mutations in a patient with childhood ILD who reached adulthood
por: Manali, Effrosyni D., et al.
Publicado: (2019)

Myelodysplastic syndromes and idiopathic pulmonary fibrosis: a dangerous liaison
por: Papiris, Spyros A., et al.
Publicado: (2019)

An algorithmic approach for the treatment of severe uncontrolled asthma
por: Zervas, Eleftherios, et al.
Publicado: (2018)

IL-26 in the Lung and Its Role in COPD Inflammation
por: Bartziokas, Konstantinos, et al.
Publicado: (2022)

Synthesis of Aryliron Complexes [CpFe(CO)(2)Ar] by Palladium-Catalyzed Reactions of [CpFe(CO)(2)I] with Arylzinc, -Boron, or -Indium Reagents
por: Yasuda, Shigeo, et al.
Publicado: (2009)

IPF-Acute Exacerbations: Advances and Future Perspectives
por: Papiris, Spyros A., et al.
Publicado: (2022)

A Real-World Observational Study Examining the Impact of Aclidinium Bromide Therapy on the Quality of Life, Symptoms, and Activity Impairment of Patients with Chronic Obstructive Pulmonary Disease: The Greek ON-AIR Study
por: Kostikas, Konstantinos, et al.
Publicado: (2020)

Decreased Serum Sirtuin-1 in COPD
por: Yanagisawa, Satoru, et al.
Publicado: (2017)

Cardiovascular Diseases in COPD: From Diagnosis and Prevalence to Therapy
por: Papaporfyriou, Anastasia, et al.
Publicado: (2023)

Serum Krebs von den Lungen-6: Promising biomarker to differentiate CPFE from IPF
por: Demirdöğen, Ezgi, et al.
Publicado: (2022)

Paucigranulocytic Asthma: Potential Pathogenetic Mechanisms, Clinical Features and Therapeutic Management
por: Papaioannou, Andriana I., et al.
Publicado: (2022)

Clinical implications for Vascular Endothelial Growth Factor in the lung: friend or foe?
por: Papaioannou, Andriana I, et al.
Publicado: (2006)

Genetics in Idiopathic Pulmonary Fibrosis: A Clinical Perspective
por: Papiris, Spyros A., et al.
Publicado: (2022)

Bench-to-bedside review: Pulmonary–renal syndromes – an update for the intensivist
por: Papiris, Spyros A, et al.
Publicado: (2007)

{CpFe(II)(CO)(2)Sn(II)(Macrocycle(•3–))} Radicals with Intrinsic Charge Transfer from CpFe(CO)(2) to Macrocycles (Cp: Cp or Cp*); Effective Magnetic Coupling between Radical Trianionic Macrocycles(•3–)
por: Konarev, Dmitri V., et al.
Publicado: (2018)

From Karl Wurm and Guy Scadding's staging to (18)F-FDG PET/CT scan phenotyping and far beyond: perspective in the evading history of phenotyping in sarcoidosis
por: Papiris, Spyros A., et al.
Publicado: (2023)

Clinical review: Idiopathic pulmonary fibrosis acute exacerbations - unravelling Ariadne's thread
por: Papiris, Spyros A, et al.
Publicado: (2010)

Sirtuin 1: Endocan and Sestrin 2 in Different Biological Samples in Patients with Asthma. Does Severity Make the Difference?
por: Tsilogianni, Zoe, et al.
Publicado: (2020)

Dual Bronchodilator in the Era of Triple Therapy
por: Papaioannou, Andriana I, et al.
Publicado: (2020)

COVID-19 in patients with pulmonary alveolar proteinosis: a European multicentre study
por: Papiris, Spyros A., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_s8nkgbuqlgpbq1ojfc8h15fops